Editorial
From the Archives
Commentary on: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP–parkinsonism, by D. Williams, R. de Silva, D. Paviour, et al. (Brain-2004-01045.R1)
Vertical nystagmus: clinical facts and hypotheses
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism
Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy
Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies
Cortico-cortical coupling in Parkinson's disease and its modulation by therapy
Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine
Colocalization of corticotropin-releasing hormone and oestrogen receptor-α in the paraventricular nucleus of the hypothalamus in mood disorders
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system
Distinct cerebral lesions in sporadic and ‘D90A’ SOD1 ALS: studies with [11C]flumazenil PET
Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study
Quantitative post-mortem study of the hippocampus in chronic epilepsy: seizures do not inevitably cause neuronal loss
Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures
Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus
Reading skills after left anterior temporal lobe resection: an fMRI study
Causes of cross-over in unilateral neglect: between-group comparisons, within-patient dissociations and eye movements
Sign and speech: amodal commonality in left hemisphere dominance for comprehension of sentences
The functional anatomy of divided attention in amnestic mild cognitive impairment
Functional recovery of children and adolescents after cerebellar tumour resection
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice
Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study
Cigarette smoking and the progression of multiple sclerosis
MULTIPLE SCLEROSIS: The history of a disease
CURING MS: How science is solving the mysteries of multiple sclerosis
Retraction
Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia—a comment
Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia
Altered central excitability and analgesic treatment in patients with restless legs syndrome